Vermont Medicaid
HPCMI: Diabetes Care for People with Serious Mental Illness: Hemoglobin A1c (HbA1c) Poor Control (>9%) (ACS-MY22)
Current Value
49
Definition
Notes on Methodology
- This is a Healthcare Effectiveness & Data Information Set (HEDIS®) hybrid measure and includes all Medicaid beneficiaries.
- The annual reported rate captures activity during the stated measurement year (MY).
The Healthcare Effectiveness Data and Information Set (HEDIS®) is a registered trademark of NCQA.
Story Behind the Curve
This measure assesses the percentage of members 18–75 years of age with a serious mental illness and diabetes (types 1 and 2) whose hemoglobin A1c (HbA1c) that was in poor control (>9%).
Diabetes is one of the most costly and highly prevalent chronic diseases in the United States. Diabetes is the seventh leading cause of death in the U.S. and killed approximately 84,000 people in 2018. Many complications such as heart disease, stroke, blindness, kidney failure and amputation can be prevented if diabetes is detected and addressed in the early stages. Controlling A1c blood levels helps reduce the risk of microvascular complications (eye, kidney and nerve diseases).
Last updated: February 2024
Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.